China Pharma R&D Surge: Hengrui and Qilu Lead Innovative Drug Push
What Happened China’s pharmaceutical industry is experiencing an unprecedented surge in research and development activity in 2026, led by Hengrui Medicine (600276.SS) and Qilu Pharmaceutical, the country’s two most R&D-intensive…
